ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics

ANIP POWR Grades

• ANIP scores best on the Growth dimension, with a Growth rank ahead of 72.5% of US stocks.
• The strongest trend for ANIP is in Momentum, which has been heading down over the past 179 days.
• ANIP's current lowest rank is in the Quality metric (where it is better than 4.36% of US stocks).

ANIP Stock Summary

• Price to trailing twelve month operating cash flow for ANIP is currently 150.1, higher than 96.91% of US stocks with positive operating cash flow.
• In terms of twelve month growth in earnings before interest and taxes, Ani Pharmaceuticals Inc is reporting a growth rate of 167.33%; that's higher than 87.98% of US stocks.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ANIP comes in at -35.13% -- higher than that of only 11.48% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Ani Pharmaceuticals Inc are DRQ, IDXG, WLL, BCOR, and ADMA.
• ANIP's SEC filings can be seen here. And to visit Ani Pharmaceuticals Inc's official web site, go to www.anipharmaceuticals.com.

ANIP Valuation Summary

• In comparison to the median Healthcare stock, ANIP's EV/EBIT ratio is 285.67% lower, now standing at -54.4.
• Over the past 243 months, ANIP's price/sales ratio has gone NA NA.
• ANIP's price/earnings ratio has moved down 8.8 over the prior 243 months.

Below are key valuation metrics over time for ANIP.

ANIP Growth Metrics

Its 5 year cash and equivalents growth rate is now at -67.31%.
• The 5 year price growth rate now stands at -27.02%.
• Its 5 year net cashflow from operations growth rate is now at 21.9%.

Over the past 49 months, ANIP's revenue has gone up $44,698,000.

The table below shows ANIP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	212.459	9.798	-22.102
2021-06-30	213.377	13.586	-17.221
2021-03-31	213.222	34.225	-15.451
2020-12-31	208.475	15.267	-22.548
2020-09-30	199.189	25.779	-23.748
2020-06-30	197.547	49.186	-20.287

ANIP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ANIP has a Quality Grade of D, ranking ahead of 9.89% of graded US stocks.
• ANIP's asset turnover comes in at 0.453 -- ranking 96th of 682 Pharmaceutical Products stocks.
• NWBO, CYTR, and NAII are the stocks whose asset turnover ratios are most correlated with ANIP.

The table below shows ANIP's key quality metrics over time.